{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:06:56Z","timestamp":1789024016307,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-149557OB-I00"],"award-info":[{"award-number":["PID2023-149557OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-143110OB-I00\/RED2024-153909-E"],"award-info":[{"award-number":["PID2022-143110OB-I00\/RED2024-153909-E"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Asociaci\u00f3n Europea contra la Leucodistrofia- ELA Spain","award":["#050601240019"],"award-info":[{"award-number":["#050601240019"]}]},{"DOI":"10.13039\/100018433","name":"Fundaci\u00f3n Hesperia","doi-asserted-by":"publisher","award":["#050601250032 \"LeukoReMy\""],"award-info":[{"award-number":["#050601250032 \"LeukoReMy\""]}],"id":[{"id":"10.13039\/100018433","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERDF\/UE","award":["RED2024-153909-E"],"award-info":[{"award-number":["RED2024-153909-E"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Loss-of-function mutations in the\n                    <jats:italic>smpd1<\/jats:italic>\n                    gene cause acid sphingomyelinase deficiency (ASMD). Early neurodegeneration and lethality characterize its infantile neurovisceral form (type A). While neuronal dysfunction was traditionally considered the primary driver of the pathology, recent evidence suggests that dysmyelination and microgliosis are not merely secondary features. Specifically, myelin debris undermines the protective role of microglia, contributing to neuroinflammation and neuronal death. Herein, we examined central myelin and oligodendrocyte lineage progression in ASM knockout mice. We show that early-onset dysmyelination results from compromised oligodendrocyte maturation driven by aberrant sphingomyelin-mediated signaling. Transcriptomic profiling revealed that mature oligodendrocytes in these mice retain a gene expression signature similar to oligodendrocyte precursor cells, indicating a differentiation arrest. The cell adhesion molecule CD44 remained significantly upregulated in mature ASMko oligodendrocytes. Pharmacological inhibition of CD44 with verbascoside rescued oligodendroglial maturation in primary culture. Verbascoside administration in vivo restored myelin integrity and improved motor behavior. These findings establish that sphingomyelin homeostasis is critical for oligodendrocyte maturation and identify myelin defects as both primary pathological triggers and therapeutic targets for ASMD with neurologic symptoms.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00503-8","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T19:31:35Z","timestamp":1786563095000},"page":"3767-3789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting CD44 reverses sphingomyelin-induced oligodendrocyte maturation arrest in acid sphingomyelinase deficiency"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3540-0015","authenticated-orcid":false,"given":"Marta","family":"Guerrero-Valero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Melgarejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Marchena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fern\u00e1ndez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Mulero-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7018-8032","authenticated-orcid":false,"given":"Fernando","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H","family":"Schuchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5679-6891","authenticated-orcid":false,"given":"Mar\u00eda Dolores","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/emmm.201302649","volume":"6","author":"AI Arroyo","year":"2014","unstructured":"Arroyo AI, Camoletto PG, Morando L, Sassoe-Pognetto M, Giustetto M, Van Veldhoven PP, Schuchman EH, Ledesma MD (2014) Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model. EMBO Mol Med 6:398\u2013413","journal-title":"EMBO Mol Med"},{"key":"503_CR2","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.4049\/jimmunol.173.7.4736","volume":"173","author":"E Avin","year":"2004","unstructured":"Avin E, Haimovich J, Hollander N (2004) Anti-idiotype \u00d7 anti-CD44 bispecific antibodies inhibit invasion of lymphoid organs by B cell lymphoma. J Immunol 173:4736\u20134743","journal-title":"J Immunol"},{"key":"503_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3614","volume":"16","author":"IS Babina","year":"2014","unstructured":"Babina IS, McSherry EA, Donatello S, Hill AD, Hopkins AM (2014) A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44. Breast Cancer Res 16:R19","journal-title":"Breast Cancer Res"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nm1279","volume":"11","author":"SA Back","year":"2005","unstructured":"Back SA, Tuohy TMF, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A et al (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11:966\u2013972","journal-title":"Nat Med"},{"key":"503_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.matbio.2007.02.002","volume":"26","author":"C Baier","year":"2007","unstructured":"Baier C, Baader SL, Jankowski J, Gieselmann V, Schilling K, Rauch U, Kappler J (2007) Hyaluronan is organized into fiber-like structures along migratory pathways in the developing mouse cerebellum. Matrix Biol 26:348\u2013358","journal-title":"Matrix Biol"},{"key":"503_CR6","doi-asserted-by":"publisher","first-page":"pdb.ip073999","DOI":"10.1101\/pdb.ip073999","volume":"2014","author":"BA Barres","year":"2014","unstructured":"Barres BA (2014) Designing and troubleshooting immunopanning protocols for purifying neural cells. Cold Spring Harb Protoc 2014:pdb.ip073999","journal-title":"Cold Spring Harb Protoc"},{"key":"503_CR7","doi-asserted-by":"publisher","first-page":"e11776","DOI":"10.15252\/emmm.201911776","volume":"12","author":"A Bartoll","year":"2020","unstructured":"Bartoll A, Toledano-Zaragoza A, Casas J, Guzm\u00e1n M, Schuchman EH, Ledesma MD (2020) Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling. EMBO Mol Med 12:e11776","journal-title":"EMBO Mol Med"},{"key":"503_CR8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/glia.20885","volume":"57","author":"NG Bauer","year":"2009","unstructured":"Bauer NG, Richter-Landsberg C, Ffrench-Constant C (2009) Role of the oligodendroglial cytoskeleton in differentiation and myelination. Glia 57:1691\u20131705","journal-title":"Glia"},{"key":"503_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871\u2013927","journal-title":"Physiol Rev"},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.semcancer.2008.03.007","volume":"18","author":"LYW Bourguignon","year":"2008","unstructured":"Bourguignon LYW (2008) Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 18:251\u2013259","journal-title":"Semin Cancer Biol"},{"key":"503_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1073\/pnas.55.2.366","volume":"55","author":"RO Brady","year":"1966","unstructured":"Brady RO, Kanfer JN, Mock MB, Fredrickson DS (1966) The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci USA 55:366\u2013369","journal-title":"Proc Natl Acad Sci USA"},{"key":"503_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2009.05947.x","volume":"109","author":"B Buccinn\u00e0","year":"2009","unstructured":"Buccinn\u00e0 B, Piccinini M, Prinetti A, Scandroglio F, Prioni S, Valsecchi M, Votta B, Grifoni S, Lupino E, Ramondetti C et al (2009) Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A. J Neurochem 109:105\u2013115","journal-title":"J Neurochem"},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"830.e13","DOI":"10.1016\/j.neurobiolaging.2011.07.006","volume":"33","author":"R Cargill","year":"2012","unstructured":"Cargill R, Kohama SG, Struve J, Su W, Banine F, Witkowski E, Back SA, Sherman LS (2012) Astrocytes in aged nonhuman primate brain gray matter synthesize excess hyaluronan. Neurobiol Aging 33:830.e13\u201324","journal-title":"Neurobiol Aging"},{"key":"503_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00280-010-1462-2","volume":"68","author":"I De Stefano","year":"2011","unstructured":"De Stefano I, Battaglia A, Zannoni GF, Prisco MG, Fattorossi A, Travaglia D, Baroni S, Renier D, Scambia G, Ferlini C et al (2011) Hyaluronic acid\u2013paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts. Cancer Chemother Pharm 68:107\u2013116","journal-title":"Cancer Chemother Pharm"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/s-2005-865863","volume":"36","author":"M Di Rocco","year":"2005","unstructured":"Di Rocco M, Rossi A, Parenti G, Allegri AEM, Filocamo M, Pessagno A, Tortori-Donati P, Minetti C, Biancheri R (2005) Different molecular mechanisms leading to white matter hypomyelination in infantile onset lysosomal disorders. Neuropediatrics 36:265\u2013269","journal-title":"Neuropediatrics"},{"key":"503_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fncel.2015.00175","volume":"9","author":"J Dzwonek","year":"2015","unstructured":"Dzwonek J, Wilczynski GM (2015) CD44: molecular interactions, signaling and functions in the nervous system. Front Cell Neurosci 9:175","journal-title":"Front Cell Neurosci"},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"pdb.prot073973","DOI":"10.1101\/pdb.prot073973","volume":"2013","author":"B Emery","year":"2013","unstructured":"Emery B, Dugas JC (2013) Purification of Oligodendrocyte Lineage Cells from Mouse Cortices by Immunopanning. Cold Spring Harb Protoc 2013:pdb.prot073973","journal-title":"Cold Spring Harb Protoc"},{"key":"503_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00005072-199909000-00001","volume":"58","author":"RD Folkerth","year":"1999","unstructured":"Folkerth RD (1999) Abnormalities of developing white matter in lysosomal storage diseases. J Neuropathol Exp Neurol 58:887\u2013902","journal-title":"J Neuropathol Exp Neurol"},{"key":"503_CR19","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899553","volume":"38","author":"E Gaband\u00e9-Rodr\u00edguez","year":"2019","unstructured":"Gaband\u00e9-Rodr\u00edguez E, P\u00e9rez-Ca\u00f1am\u00e1s A, Soto-Huelin B, Mitroi DN, S\u00e1nchez-Redondo S, Mart\u00ednez-S\u00e1ez E, Venero C, Peinado H, Ledesma MD (2019) Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders. EMBO J 38:e99553","journal-title":"EMBO J"},{"key":"503_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.mcn.2005.07.003","volume":"30","author":"C Galvan","year":"2005","unstructured":"Galvan C, Camoletto PG, Dotti CG, Aguzzi A, Ledesma MD (2005) Proper axonal distribution of PrP(C) depends on cholesterol-sphingomyelin-enriched membrane domains and is developmentally regulated in hippocampal neurons. Mol Cell Neurosci 30:304\u2013315","journal-title":"Mol Cell Neurosci"},{"key":"503_CR21","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Mart\u00edn P, Mac\u00edas-Castellano A, Fern\u00e1ndez-G\u00f3mez B, S\u00e1nchez-Jim\u00e9nez E, Marchena M, de Castro F (2025) Isolation of oligodendrocyte precursor cells with immunomagnetic beads for their better viability in vitro and in vivo. In: Ortega F (ed) Neural stem cells: methods and protocols. Springer US, New York, NY, pp 47\u201357","DOI":"10.1007\/978-1-0716-4386-0_4"},{"key":"503_CR22","doi-asserted-by":"publisher","first-page":"17041","DOI":"10.1074\/jbc.M114.610204","volume":"290","author":"M Hartmann","year":"2015","unstructured":"Hartmann M, Parra LM, Ruschel A, Lindner C, Morrison H, Herrlich A, Herrlich P (2015) Inside-out regulation of ectodomain cleavage of cluster-of-differentiation-44 (CD44) and of neuregulin-1 requires substrate dimerization*\u2666. J Biol Chem 290:17041\u201317054","journal-title":"J Biol Chem"},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-04-0129","volume":"64","author":"S Hibino","year":"2004","unstructured":"Hibino S, Shibuya M, Engbring JA, Mochizuki M, Nomizu M, Kleinman HK (2004) Identification of an active site on the laminin \u03b15 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 64:4810\u20134816","journal-title":"Cancer Res"},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1194\/jlr.D500040-JLR200","volume":"47","author":"MR Hojjati","year":"2006","unstructured":"Hojjati MR, Jiang X-C (2006) Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J Lipid Res 47:673\u2013676","journal-title":"J Lipid Res"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ng0795-288","volume":"10","author":"K Horinouchi","year":"1995","unstructured":"Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sandhoff K, Desnick RJ, Stewart CL, Schuchman EH (1995) Acid sphingomyelinase deficient mice: a model of types A and B Niemann\u2013Pick disease. Nat Genet 10:288\u2013293","journal-title":"Nat Genet"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nm1483","volume":"12","author":"L Jin","year":"2006","unstructured":"Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE (2006) Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12:1167\u20131174","journal-title":"Nat Med"},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/cells12111483","volume":"12","author":"PK Kruk","year":"2023","unstructured":"Kruk PK, Nader K, Skupien-Jaroszek A, W\u00f3jtowicz T, Buszka A, Olech-Kocha\u0144czyk G, Wilczynski GM, Worch R, Kalita K, W\u0142odarczyk J et al (2023) Astrocytic CD44 deficiency reduces the severity of kainate-induced epilepsy. Cells 12:1483","journal-title":"Cells"},{"key":"503_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39733-6","volume":"14","author":"TJ Kunkel","year":"2023","unstructured":"Kunkel TJ, Townsend A, Sullivan KA, Merlet J, Schuchman EH, Jacobson DA, Lieberman AP (2023) The cholesterol transporter NPC1 is essential for epigenetic regulation and maturation of oligodendrocyte lineage cells. Nat Commun 14:3964","journal-title":"Nat Commun"},{"key":"503_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF00688472","volume":"63","author":"P Landrieu","year":"1984","unstructured":"Landrieu P, Sa\u00efd G (1984) Peripheral neuropathy in type A Niemann-Pick disease. A morphological study. Acta Neuropathol (Berl) 63:66\u201371","journal-title":"Acta Neuropathol (Berl)"},{"key":"503_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1471-4159.2010.07034.x","volume":"116","author":"MD Ledesma","year":"2011","unstructured":"Ledesma MD, Prinetti A, Sonnino S, Schuchman EH (2011) Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice. J Neurochem 116:779\u2013788","journal-title":"J Neurochem"},{"key":"503_CR31","first-page":"2702","volume":"159","author":"D Liu","year":"1997","unstructured":"Liu D, Sy MS (1997) Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J Immunol Balt Md 159:2702\u20132711","journal-title":"J Immunol Balt Md"},{"key":"503_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ydbio.2004.08.018","volume":"276","author":"Y Liu","year":"2004","unstructured":"Liu Y, Han SSW, Wu Y, Tuohy TMF, Xue H, Cai J, Back SA, Sherman LS, Fischer I, Rao MS (2004) CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol 276:31\u201346","journal-title":"Dev Biol"},{"key":"503_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/glia.23936","volume":"69","author":"C Melero-Jerez","year":"2021","unstructured":"Melero-Jerez C, Fern\u00e1ndez-G\u00f3mez B, Lebr\u00f3n-Gal\u00e1n R, Ortega MC, S\u00e1nchez-de Lara I, Ojalvo AC, Clemente D, de Castro F (2021) Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation. Glia 69:905\u2013924","journal-title":"Glia"},{"key":"503_CR34","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00429-014-0977-4","volume":"221","author":"V Murcia-Belmonte","year":"2016","unstructured":"Murcia-Belmonte V, Esteban PF, Mart\u00ednez-Hern\u00e1ndez J, Gruart A, Luj\u00e1n R, Delgado-Garc\u00eda JM, de Castro F (2016) Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness. Brain Struct Funct 221:1365\u20131385","journal-title":"Brain Struct Funct"},{"key":"503_CR35","doi-asserted-by":"publisher","first-page":"e53109","DOI":"10.1371\/journal.pone.0053109","volume":"8","author":"M Naruse","year":"2013","unstructured":"Naruse M, Shibasaki K, Yokoyama S, Kurachi M, Ishizaki Y (2013) Dynamic changes of CD44 expression from progenitors to subpopulations of astrocytes and neurons in developing cerebellum. PLoS ONE 8:e53109","journal-title":"PLoS ONE"},{"key":"503_CR36","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/glia.24540","volume":"72","author":"S Nocera","year":"2024","unstructured":"Nocera S, Marchena MA, Fern\u00e1ndez-G\u00f3mez B, G\u00f3mez-Mart\u00edn P, S\u00e1nchez-Jim\u00e9nez E, Mac\u00edas-Castellano A, La\u00f3 Y, Cordano C, G\u00f3mez-Torres \u00d3, Luj\u00e1n R et al (2024) Activation of Shh\/Smo is sufficient to maintain oligodendrocyte precursor cells in an undifferentiated state and is not necessary for myelin formation and (re)myelination. Glia 72:1469\u20131483","journal-title":"Glia"},{"key":"503_CR37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1083\/jcb.146.4.843","volume":"146","author":"S Oliferenko","year":"1999","unstructured":"Oliferenko S, Paiha K, Harder T, Gerke V, Schw\u00e4rzler C, Schwarz H, Beug H, G\u00fcnthert U, Huber LA (1999) Analysis of Cd44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol 146:843\u2013854","journal-title":"J Cell Biol"},{"key":"503_CR38","doi-asserted-by":"crossref","unstructured":"Ozarkar SS, Patel RKR, Vulli T, Friar CA, Burette AC, Philpot BD (2025) Regional analysis of myelin basic protein across postnatal brain development of C57BL\/6J mice. Front Neuroanat 19:1535745","DOI":"10.3389\/fnana.2025.1535745"},{"key":"503_CR39","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, Gauthier C, Jacques P-\u00c9, Li S, Xia J (2021) MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49:W388\u2013W396","journal-title":"Nucleic Acids Res"},{"key":"503_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/mp.2016.148","volume":"22","author":"A P\u00e9rez-Ca\u00f1am\u00e1s","year":"2017","unstructured":"P\u00e9rez-Ca\u00f1am\u00e1s A, Benvegn\u00f9 S, Rueda CB, R\u00e1bano A, Satr\u00fastegui J, Ledesma MD (2017) Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease. Mol Psychiatry 22:711\u2013723","journal-title":"Mol Psychiatry"},{"key":"503_CR41","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.3390\/ijms21175988","volume":"21","author":"A Peters","year":"2020","unstructured":"Peters A, Sherman LS (2020) Diverse roles for hyaluronan and hyaluronan receptors in the developing and adult nervous system. Int J Mol Sci 21:5988","journal-title":"Int J Mol Sci"},{"key":"503_CR42","unstructured":"Quarles RH, Morell Macklin WB, P (2006) Myelin formation, structure and biochemistry. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD (eds) Basic neurochemistry: molecular, cellular and medical aspects. Elsevier Academic Press, pp 51\u201371"},{"key":"503_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fcell.2020.00283","volume":"8","author":"MDA Rahman","year":"2020","unstructured":"Rahman MDA, Saha SK, Rahman MS, Uddin MJ, Uddin MDS, Pang M-G, Rhim H, Cho S-G (2020) Molecular insights into therapeutic potential of autophagy modulation by natural products for cancer stem cells. Front Cell Dev Biol 8:283","journal-title":"Front Cell Dev Biol"},{"key":"503_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat3738","volume":"11","author":"L Samaranch","year":"2019","unstructured":"Samaranch L, P\u00e9rez-Ca\u00f1am\u00e1s A, Soto-Huelin B, Sudhakar V, Jurado-Arjona J, Hadaczek P, \u00c1vila J, Bringas JR, Casas J, Chen H et al (2019) Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A. Sci Transl Med 11:eaat3738","journal-title":"Sci Transl Med"},{"key":"503_CR45","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1046\/j.0953-816x.2001.01564.x","volume":"13","author":"J Sarna","year":"2001","unstructured":"Sarna J, Miranda SR, Schuchman EH, Hawkes R (2001) Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A\/B disease. Eur J Neurosci 13:1873\u20131880","journal-title":"Eur J Neurosci"},{"key":"503_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbrc.2022.07.092","volume":"624","author":"T Sato","year":"2022","unstructured":"Sato T, Shirai R, Isogai M, Yamamoto M, Miyamoto Y, Yamauchi J (2022) Hyaluronic acid and its receptor CD44, acting through TMEM2, inhibit morphological differentiation in oligodendroglial cells. Biochem Biophys Res Commun 624:102\u2013111","journal-title":"Biochem Biophys Res Commun"},{"key":"503_CR47","doi-asserted-by":"publisher","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji\u2014an open source platform for biological image analysis. Nat Methods. https:\/\/doi.org\/10.1038\/nmeth.2019","DOI":"10.1038\/nmeth.2019"},{"key":"503_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","volume":"120","author":"EH Schuchman","year":"2017","unstructured":"Schuchman EH, Desnick RJ (2017) Types A and B Niemann-Pick disease. Mol Genet Metab 120:27\u201333","journal-title":"Mol Genet Metab"},{"key":"503_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/glia.10321","volume":"45","author":"A Setzu","year":"2004","unstructured":"Setzu A, Ffrench-Constant C, Franklin RJM (2004) CNS axons retain their competence for myelination throughout life. Glia 45:307\u2013311","journal-title":"Glia"},{"key":"503_CR50","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-09-0143","volume":"69","author":"MG Slomiany","year":"2009","unstructured":"Slomiany MG, Dai L, Bomar PA, Knackstedt TJ, Kranc DA, Tolliver L, Maria BL, Toole BP (2009) Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res 69:4992\u20134998","journal-title":"Cancer Res"},{"key":"503_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0012-1606(81)90477-2","volume":"83","author":"I Sommer","year":"1981","unstructured":"Sommer I, Schachner M (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83:311\u2013327","journal-title":"Dev Biol"},{"key":"503_CR52","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1074\/jbc.M116.774109","volume":"292","author":"W Su","year":"2017","unstructured":"Su W, Foster SC, Xing R, Feistel K, Olsen RHJ, Acevedo SF, Raber J, Sherman LS (2017) CD44 transmembrane receptor and hyaluronan regulate adult hippocampal neural stem cell quiescence and differentiation *. J Biol Chem 292:4434\u20134445","journal-title":"J Biol Chem"},{"key":"503_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/jdb4030028","volume":"4","author":"E Traiffort","year":"2016","unstructured":"Traiffort E, Zakaria M, Laouarem Y, Ferent J (2016) Hedgehog: a key signaling in the development of the oligodendrocyte lineage. J Dev Biol 4:28","journal-title":"J Dev Biol"},{"key":"503_CR54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/glia.20042","volume":"47","author":"TMF Tuohy","year":"2004","unstructured":"Tuohy TMF, Wallingford N, Liu Y, Chan FH, Rizvi T, Xing R, Bebo B, Rao MS, Sherman LS (2004) CD44 overexpression by oligodendrocytes: a novel mouse model of inflammation-independent demyelination and dysmyelination. Glia 47:335\u2013345","journal-title":"Glia"},{"key":"503_CR55","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1111\/bph.15030","volume":"177","author":"C Wang","year":"2020","unstructured":"Wang C, Wang Z, Chen C, Fu X, Wang J, Fei X, Yan X, Xu R (2020) A low MW inhibitor of CD44 dimerization for the treatment of glioblastoma. Br J Pharm 177:3009\u20133023","journal-title":"Br J Pharm"},{"key":"503_CR56","doi-asserted-by":"publisher","first-page":"106133","DOI":"10.1016\/j.phrs.2022.106133","volume":"177","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li L, Wu Y, Zhang S, Ju Q, Yang Y, Jin Y, Shi H, Sun C (2022) CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson\u2019s disease. Pharm Res 177:106133","journal-title":"Pharm Res"},{"key":"503_CR57","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10545-017-0123-6","volume":"41","author":"MP Wasserstein","year":"2018","unstructured":"Wasserstein MP, Diaz GA, Lachmann RH, Jouvin M-H, Nandy I, Ji AJ, Puga AC (2018) Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months. J Inherit Metab Dis 41:829\u2013838","journal-title":"J Inherit Metab Dis"},{"key":"503_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41582-020-00432-1","volume":"17","author":"NI Wolf","year":"2021","unstructured":"Wolf NI, Ffrench-Constant C, van der Knaap MS (2021) Hypomyelinating leukodystrophies\u2014unravelling myelin biology. Nat Rev Neurol 17:88\u2013103","journal-title":"Nat Rev Neurol"},{"key":"503_CR59","doi-asserted-by":"publisher","first-page":"952135","DOI":"10.3389\/fcell.2022.952135","volume":"10","author":"M Yamada","year":"2022","unstructured":"Yamada M, Iwase M, Sasaki B, Suzuki N (2022) The molecular regulation of oligodendrocyte development and CNS myelination by ECM proteins. Front Cell Dev Biol 10:952135","journal-title":"Front Cell Dev Biol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00503-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:31:54Z","timestamp":1789021914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,10]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00503-8","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}